Owlstone Medical Overview

  • Founded
  • 2003

Founded
  • Status
  • Private

  • Employees
  • 200

Employees
  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $60.4M

  • Investors
  • 8

Owlstone Medical General Information

Description

Developer of breathalyzer designed to focus on non-invasive diagnostics for the early detection of disease and on precision medicine. The company is developing a biopsy product and a proprietary sample collection device that can take stable breath samples anywhere, enabling doctors to avail detection of diseases including lung cancer, liver disease, digestive health, and respiratory disease.

Contact Information

Formerly Known As
Tiger Dawn
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 183 Cambridge Science Park
  • Milton Road
  • Cambridge CB4 0GF
  • England, United Kingdom
+44 01223 000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Owlstone Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series D) 31-Aug-2021 $60.4M 00000 00000 Completed Generating Revenue
6. Later Stage VC 01-Oct-2018 000.00 00000 00000 Completed Generating Revenue
5. Grant 25-Jan-2018 00000 000.00 Completed Generating Revenue
4. Later Stage VC 27-Mar-2017 00.000 000.00 Completed Generating Revenue
3. Later Stage VC 06-Jan-2017 000.00 000.00 000.00 Completed Generating Revenue
2. Grant 11-Dec-2016 $1.38M $7.27M Completed Generating Revenue
1. Angel (individual) 28-Jun-2016 $7.27M $7.27M 000.00 Completed Generating Revenue
To view Owlstone Medical’s complete valuation and funding history, request access »

Owlstone Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary 0,000 00.000000 00.00 00.00 00 00.00 0.000
D Ordinary 0,000,000 00.000000 000.00 000.00 00 000.00 00.000
A Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 0.000
C Ordinary 00,000 00.000000 000 000 00 000 0.000
C Ordinary 0,000,000 00.000000 000.00 000.00 00 000.00 0.00
C Ordinary 000,000 00.000000 000.00 000.00 00 000.00 00
C Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.000
C Ordinary 000,000 00.000000 000.00 000.00 00 000.00 0.000
C Ordinary 443,787 $0.000138 $17.83 $17.83 1x $17.83 3.21%
Convertible C 376,330 $0.000138 $18.09 $18.09 1x $18.09 2.72%
To view Owlstone Medical’s complete cap table history, request access »

Owlstone Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of breathalyzer designed to focus on non-invasive diagnostics for the early detection of disease and on precis
Diagnostic Equipment
Cambridge, United Kingdom
200 As of 2022
00000
0000 0000-00-00
00000000000 00000

000000

rehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat c
0000000000 000000000
Louisville, KY
0 As of 0000
000
000 0000-00-00
000000000 000

000000

tion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
0000000000 000000000
Angelholm, Sweden
000 As of 0000
0000 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Owlstone Medical Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Breath Diagnostics Venture Capital-Backed Louisville, KY 0 000 000000000 000
0000000 Corporate Backed or Acquired Angelholm, Sweden 000 000000&0
00000 0000000 Private Equity-Backed Orlando, FL 0000 000.00 000000000000 000.00
00 0000000000 Corporation Boston, MA 00000 000
0000000 Venture Capital-Backed Fitchburg, WI 0 00.000 00000000000 00.000
You’re viewing 5 of 5 competitors. Get the full list »

Owlstone Medical Patents

Owlstone Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202208155-D0 Method Pending 01-Jun-2022
GB-202207291-D0 Detection of liver disease Pending 18-May-2022
GB-202114706-D0 Method Pending 14-Oct-2021
GB-202110582-D0 Breath sampling device Pending 22-Jul-2021
GB-202107203-D0 Formulation Inactive 20-May-2021
To view Owlstone Medical’s complete patent history, request access »

Owlstone Medical Executive Team (11)

Name Title Board Seat Contact Info
Billy Boyle Co-Founder, Chief Executive Officer & Board Member
Neil Tween Chief Financial Officer
David Ruiz-Alonso Ph.D Co-Founder & Chief Operating Officer
Max Allsworth Chief Science Officer
Alastair Taylor Owlstone Fellow
You’re viewing 5 of 11 executive team members. Get the full list »

Owlstone Medical Board Members (7)

Name Representing Role Since
Andy Richards Ph.D Self Chairman 000 0000
Billy Boyle Owlstone Medical Co-Founder, Chief Executive Officer & Board Member 000 0000
Bret Bader Self Board Member 000 0000
Christofer Toumazou Ph.D Self Board Member 000 0000
Doug Wright Aviva Ventures Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Owlstone Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Owlstone Medical Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Hon Hai Precision Corporation Minority 000 0000 000000 0
Horizons Ventures Venture Capital Minority 000 0000 000000 0
V Ventures Venture Capital Minority 000 0000 000000 0
IPF Catalyst Challenge Not-For-Profit Venture Capital 000 0000 000000 0
Aviva Ventures Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »